ChemicalBook >> CAS DataBase List >>DOXEPIN

DOXEPIN

CAS No.
1668-19-5
Chemical Name:
DOXEPIN
Synonyms
Doxepine;3-(DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE;Aponal;p3693a;Curatin;Docepin;P-3693A;DOXEPIN;Quitaxon;NSC-108160
CBNumber:
CB5113073
Molecular Formula:
C19H21NO
Molecular Weight:
279.38
MDL Number:
MFCD00865448
MOL File:
1668-19-5.mol
MSDS File:
SDS
Last updated:2026-07-27 17:00:41

DOXEPIN Properties

Melting point 187-189°C
Boiling point bp0.03 154-157°; bp0.2 260-270°
Density 1.0594 (rough estimate)
refractive index 1.5000 (estimate)
storage temp. Sealed in dry,2-8°C
pka 9.40±0.28(Predicted)
Water Solubility 31.57mg/L(25 ºC)
FDA UNII 5ASJ6HUZ7D
EPA Substance Registry System Doxepin (1668-19-5)

SAFETY

Risk and Safety Statements

Hazard Codes  T
Risk Statements  25
Safety Statements  36/37/39-45
Hazardous Substances Data 1668-19-5(Hazardous Substances Data)
Toxicity LD50 in mice, rats (mg/kg): 26, 16 i.v.; 79, 182 i.p.; 135, 147 orally (Ribbentrop, Schaumann)

DOXEPIN price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0013584 Doxepin 99.66% 1668-19-5 5mg $38 2026-06-04 Buy
ChemScene CS-0013584 Doxepin 99.66% 1668-19-5 10mg $65 2026-06-04 Buy
ChemScene CS-0013584 Doxepin 99.66% 1668-19-5 25mg $125 2026-06-04 Buy
ChemScene CS-0013584 Doxepin 99.66% 1668-19-5 50mg $200 2026-06-04 Buy
ChemScene CS-0013584 Doxepin 99.66% 1668-19-5 100mg $325 2026-06-04 Buy
Product number Packaging Price Buy
CS-0013584 5mg $38 Buy
CS-0013584 10mg $65 Buy
CS-0013584 25mg $125 Buy
CS-0013584 50mg $200 Buy
CS-0013584 100mg $325 Buy

DOXEPIN Chemical Properties,Uses,Production

Chemical Properties

The mixture of cis and trans isomers is an oily liquid with a boiling point of 260-270°C (2.66×10-2kPa) and 154-157°C (3.99×10-3kPa). Its hydrochloride ([1229-29-4]), melting point 188-189 ℃.

Originator

Sinequan,Pfizer,US,1969

Uses

Used clinically to treat anxiety and depression. Antidepressant

Definition

ChEBI: A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Manufacturing Process

(A) Preparation of 3-bromopropyltriphenylphosphonium bromide: Triphenylphosphine, 1.0 kg, and 770 grams of 1,3-dibromopropane are dissolved in 2.0 liters of xylene and the solution is stirred under a nitrogen atmosphere at 130°C. After 20 hours the mixture is cooled, and the crystalline product, which precipitates, is collected and washed with 20 liters of benzene. After drying in vacuo the product weighs 1,578 grams, MP 229°-230°C;titration for bromide ion: Found, 17.1%; calculated, 17.2%.
(B) Preparation of 3-dimethylaminopropyltriphenylphosphonium bromide hydrobromide: A solution of 595 grams of anhydrous dimethylamine and 1,358 grams of 3-bromopropyl-triphenylphosphonium bromide in 4 liters of ethanol is warmed to 70°C until solution is complete and the solution then is allowed to stand at room temperature for 20 hours. Volatile components are removed by distillation in a vacuum and the residue is suspended in 2.0 liters of ethanol and is redistilled to remove excess amine. The residue is dissolved in 3.0 liters of warm ethanol and gaseous hydrogen bromide is passed into the solution until the mixture is acidic. After filtration the solution is concentrated to a volume of 3.0 liters, is cooled, whereupon the product precipitates, and the precipitate is collected; it weighs 1,265 grams, MP 274- 281°C. Recrystallization from ethanol raises the MP to 280.5°-282.5°C. Bromide ion titration: Found, 31.2%; calculated 31.3%.
(C) Preparation of doxepin: 1,530 grams of the product from step (B) is suspended in 4.5 liters dry tetrahydrofuran and 6.0 mols of butyl lithium in heptane is added during 1 hour. After an additional 30 minutes, 483 grams of 6,11-dihydrodibenz-(b,e)oxepin-11-one, prepared as described in Belgian Patent 641,498, is added to the deep red solution and the reaction was maintained at reflux for 10 hours. Water, 500 ml, is added at room temperature and the solvent is removed in vacuo. The crude residue is treated with 10% hydrochloric acid until acidic (pH 2) and then 1.5 liters benzene is added. After stirring, the mixture separates into 3 phases (an insoluble hydrochloride salt product phase, an aqueous phase and an organic phase).
The benzene layer is removed by decantation and the remaining mixture is rendered basic with 10% sodium hydroxide solution and is extracted with three 1,500 ml portions of benzene. The benzene extracts are washed, then dried with anhydrous sodium sulfate and concentrated in a vacuum leaving a residue of 1,530 grams, gas and thin layer chromatography analysis show this to be a cis/trans mixture (approx. 4:l) of 11-dimethylaminopropylidene-6,11- dihydrodibenz-(b,e)oxepin (90% yield). This mixture has substantially more activity pharmacologically than the cis/trans mixture obtained by the Grignard route disclosed in the Belgian Patent 641,498. This base is then converted to the hydrochloride with HCl.

brand name

Apo-doxepin;Co dox;Deptran;Doksapan;Dolat;Doxal;Doxedyn;Doxepin hcl;Gilex;Novo-doxepin;Novoxapin;Sinequan;Sinquan concentrate;Sinquane;Tolllluan;Triadapin;Zonalon.

Therapeutic Function

Tranquilizer

World Health Organization (WHO)

Doxepin, a tricyclic antidepressant was introduced in 1964 for the management of endogenous depression. Much of the adverse effects are caused by its antimuscarinic actions. These include dry mouth, cardiac arrhythmias, central nervous system disturbances, blood disorders and risk of suicide. The risk of suicide and dangers related to overdosage led the Norwegian Medicines Control Authority to put the higher strength formulation under prescribing restriction in 1992. The risk of death following overdosage is apparently higher for products containing tricyclic compounds as compared with nontricyclic products.

Biological Activity

Highly potent H 1 histamine receptor antagonist (K d = 310 pM) and tricyclic antidepressant. Also binds to the H 4 histamine receptor (pK i = 6.79).

Contact allergens

This benzoxepin tricylcic drug has antidepressant, anticholinergic, antiitching, and antihistamine properties. After oral use, it has been developed as a topical antiitching agent. Allergic contact dermatitis is not infrequent.

Global( 45)Suppliers
Supplier Tel Email Country ProdList Advantage
3B Pharmachem (Wuhan) International Co.,Ltd. 18930552037 3bsc@sina.com China 15813 69
LGM Pharma 1-(800)-881-8210 inquiries@lgmpharma.com United States 2110 70
Beijing HuaMeiHuLiBiological Chemical 010-56205725 waley188@sohu.com China 12323 58
EMMX Biotechnology LLC 888-539-0666 info@emmx.com United States 8435 60
BOC Sciences 16314854226 info@bocsci.com United States 9909 65
Artis Biotech Co. Ltd. 18108108965 18108108965 sales@artisbio.com China 2503 58
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
Shanghai Zhen Li Biological Technology Co., Ltd 021-16621358918; 18516310516;16621358918;13045646768 zhenlipharma888@163.com China 19060 58
Aikon International Limited 025-58859352 19370895928 sales01@aikonchem.com China 15078 58
Dideu Industries Group Limited +8617392712697 1022@dideu.com China 29091 58

View Lastest Price from DOXEPIN manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
DOXEPIN USP/EP/BP pictures 2026-08-20 DOXEPIN USP/EP/BP
1668-19-5
$1.10 1g 99.9% 100 Tons min Dideu Industries Group Limited
Doxepin pictures 2026-07-27 Doxepin
1668-19-5
$1520.00-2500.00 10g TargetMol Chemicals Inc.
DOXEPIN pictures 2020-01-10 DOXEPIN
1668-19-5
$7.00 1KG 99% 100KG Career Henan Chemical Co
  • Doxepin pictures
  • Doxepin
    1668-19-5
  • $1520.00-2500.00
  • TargetMol Chemicals Inc.
  • DOXEPIN pictures
  • DOXEPIN
    1668-19-5
  • $7.00
  • 99%
  • Career Henan Chemical Co
(3Z)-3-Dibenzo[b,E]oxepin-11(6H)-ylidene-N,N-dimethyl-1-propanamine 11-(3-(dimethylamino)propylidene)-6h-dibenz(b,e)0xepine 11-(3-dimethylamino-propyliden)-6,11-dihydro-dibenz(b,e)oxipin 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz(b,e)oxipin 3-dibenz(b,e)oxepin-11(6h)-ylidene-n,n-dimethyl-1-propanamin Quitaxon 1-Propanamine, 3-dibenzb,eoxepin-11(6H)-ylidene-N,N-dimethyl- 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin N,N-Dimethyl-3-(6,11-dihydrodibenz[b,e]oxepin-11-ylidene)propylamine Cidoxepin 1668-19-5 3-Dibenz[b,e]oxepin-(6H)-ylidene-N,N-dimethyl-1-propanamine 3-Dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-1-propanamine Aponal Curatin Dibenz(b,e)oxepin-delta11(6H),gamma-propylamine, N,N-dimethyl- Docepin e)oxepin-delta(11(6h),gamma)-propylamine,n,n-dimethyl-dibenz( e)oxepin-delta(sup11(6h)),gamma-propylamine,n,n-dimethyl-dibenz( n,n-dimethyldibenz(b,e)oxepin-delta(11(6h),gamma)-propylamine NSC-108160 p3693a P-3693A DOXEPIN USP/EP/BP Doxepin-13C D3 DOXEPIN 3-(DIBENZO[B,E]OXEPIN-11(6H)-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE Doxepine 1668-19-5 C19H21NO11HCl C19H22NO Heterocyclic Compounds Neurochemicals